Welcome toRemove term: CBD and Hemp Legal and Regulatory Roundup CBD and Hemp Legal and Regulatory Roundup our weekly roundup of CBD and hemp-related legal and regulatory news:

CBD

Physicians remain reluctant to prescribe CBD for epilepsy

While the FDA has approved cannabis-derived prescription drug, Epidiolex, for three rare seizure disorders, not much has changed
Continue Reading CBD and Hemp Legal and Regulatory Roundup – July 15, 2022

Partner Jaimie Nawaday authored “How to Navigate a State Regulatory Investigation Into Your Cannabis Business” in the Cannabis Business Times.

In this article, Nawaday unpacks how to protect new licensees and navigate an investigation to a


Continue Reading How to Navigate a State Regulatory Investigation Into Your Cannabis Business

KDW COVID-19 Resource Center Provides Critical Business Guidance As the novel coronavirus (COVID-19) has reached pandemic levels, companies of all sizes and in all industries face myriad impacts to business operations and the health and well-being of employees.

To help clients navigate these new challenges, including the unpredictability
Continue Reading KDW COVID-19 Resource Center Provides Critical Business Guidance

The push and pull on CBD regulation continues.

Earlier this week, Minnesota Representative Colin Peterson introduced a H.R. 5587, which would regulate CBD as a dietary supplement.  Specifically, the bill would amend the federal Food, Drug, and Cosmetic Act
Continue Reading House Bill Introduced to Treat CBD as Dietary Supplement While FDA Grapples With Reporting Deadlines and Data Gaps